MAP Publication

ISPOR 2018 – Barcelona: Bridging the gap: Ensuring fair assessment of orphan treatments by health technology assessments in England

2018 |

Although some orphan treatments benefit from end-of-life criteria, and oncology drugs may qualify for interim NHS England funding through the Cancer Drugs Fund, there are no adjustments in evidence requirements or approach for orphan treatments. This study explores the impact of these disparities.


All Publications